IBDEI21B ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,35555,2)
 ;;=^267324
 ;;^UTILITY(U,$J,358.3,35556,0)
 ;;=C78.39^^188^2050^19
 ;;^UTILITY(U,$J,358.3,35556,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35556,1,3,0)
 ;;=3^Secondary malignant neoplasm of other respiratory organs
 ;;^UTILITY(U,$J,358.3,35556,1,4,0)
 ;;=4^C78.39
 ;;^UTILITY(U,$J,358.3,35556,2)
 ;;=^267325
 ;;^UTILITY(U,$J,358.3,35557,0)
 ;;=I27.9^^189^2051^1
 ;;^UTILITY(U,$J,358.3,35557,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35557,1,3,0)
 ;;=3^Pulmonary heart disease, unspecified
 ;;^UTILITY(U,$J,358.3,35557,1,4,0)
 ;;=4^I27.9
 ;;^UTILITY(U,$J,358.3,35557,2)
 ;;=^5007154
 ;;^UTILITY(U,$J,358.3,35558,0)
 ;;=D61.09^^189^2052^4
 ;;^UTILITY(U,$J,358.3,35558,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35558,1,3,0)
 ;;=3^Constitutional aplastic anemia NEC
 ;;^UTILITY(U,$J,358.3,35558,1,4,0)
 ;;=4^D61.09
 ;;^UTILITY(U,$J,358.3,35558,2)
 ;;=^334036
 ;;^UTILITY(U,$J,358.3,35559,0)
 ;;=D61.810^^189^2052^1
 ;;^UTILITY(U,$J,358.3,35559,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35559,1,3,0)
 ;;=3^Antineoplastic chemotherapy induced pancytopenia
 ;;^UTILITY(U,$J,358.3,35559,1,4,0)
 ;;=4^D61.810
 ;;^UTILITY(U,$J,358.3,35559,2)
 ;;=^5002339
 ;;^UTILITY(U,$J,358.3,35560,0)
 ;;=D61.2^^189^2052^2
 ;;^UTILITY(U,$J,358.3,35560,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35560,1,3,0)
 ;;=3^Aplastic anemia due to other external agents
 ;;^UTILITY(U,$J,358.3,35560,1,4,0)
 ;;=4^D61.2
 ;;^UTILITY(U,$J,358.3,35560,2)
 ;;=^5002337
 ;;^UTILITY(U,$J,358.3,35561,0)
 ;;=D61.1^^189^2052^5
 ;;^UTILITY(U,$J,358.3,35561,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35561,1,3,0)
 ;;=3^Drug-induced aplastic anemia
 ;;^UTILITY(U,$J,358.3,35561,1,4,0)
 ;;=4^D61.1
 ;;^UTILITY(U,$J,358.3,35561,2)
 ;;=^5002336
 ;;^UTILITY(U,$J,358.3,35562,0)
 ;;=D61.89^^189^2052^3
 ;;^UTILITY(U,$J,358.3,35562,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35562,1,3,0)
 ;;=3^Aplastic anemias and other bone marrow failure syndromes NEC
 ;;^UTILITY(U,$J,358.3,35562,1,4,0)
 ;;=4^D61.89
 ;;^UTILITY(U,$J,358.3,35562,2)
 ;;=^5002341
 ;;^UTILITY(U,$J,358.3,35563,0)
 ;;=K40.90^^189^2053^3
 ;;^UTILITY(U,$J,358.3,35563,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35563,1,3,0)
 ;;=3^Unil inguinal hernia w/o obstruction or gangrene
 ;;^UTILITY(U,$J,358.3,35563,1,4,0)
 ;;=4^K40.90
 ;;^UTILITY(U,$J,358.3,35563,2)
 ;;=^5008591
 ;;^UTILITY(U,$J,358.3,35564,0)
 ;;=K42.9^^189^2053^2
 ;;^UTILITY(U,$J,358.3,35564,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35564,1,3,0)
 ;;=3^Umbilical hernia w/o obstruction or gangrene
 ;;^UTILITY(U,$J,358.3,35564,1,4,0)
 ;;=4^K42.9
 ;;^UTILITY(U,$J,358.3,35564,2)
 ;;=^5008606
 ;;^UTILITY(U,$J,358.3,35565,0)
 ;;=K43.9^^189^2053^4
 ;;^UTILITY(U,$J,358.3,35565,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35565,1,3,0)
 ;;=3^Ventral hernia w/o obstruction or gangrene
 ;;^UTILITY(U,$J,358.3,35565,1,4,0)
 ;;=4^K43.9
 ;;^UTILITY(U,$J,358.3,35565,2)
 ;;=^5008615
 ;;^UTILITY(U,$J,358.3,35566,0)
 ;;=K43.2^^189^2053^1
 ;;^UTILITY(U,$J,358.3,35566,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35566,1,3,0)
 ;;=3^Incisional hernia w/o obstruction or gangrene
 ;;^UTILITY(U,$J,358.3,35566,1,4,0)
 ;;=4^K43.2
 ;;^UTILITY(U,$J,358.3,35566,2)
 ;;=^5008609
 ;;^UTILITY(U,$J,358.3,35567,0)
 ;;=N17.0^^189^2054^1
 ;;^UTILITY(U,$J,358.3,35567,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35567,1,3,0)
 ;;=3^Acute kidney failure with tubular necrosis
 ;;^UTILITY(U,$J,358.3,35567,1,4,0)
 ;;=4^N17.0
 ;;^UTILITY(U,$J,358.3,35567,2)
 ;;=^5015598
 ;;^UTILITY(U,$J,358.3,35568,0)
 ;;=N18.9^^189^2054^2
 ;;^UTILITY(U,$J,358.3,35568,1,0)
 ;;=^358.31IA^4^2
 ;;
 ;;$END ROU IBDEI21B
